X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (20317) 20317
Newsletter (264) 264
Newspaper Article (85) 85
Magazine Article (59) 59
Book Chapter (56) 56
Dissertation (10) 10
Transcript (9) 9
Publication (4) 4
Conference Proceeding (3) 3
Book / eBook (2) 2
Report (2) 2
Book Review (1) 1
Government Document (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (17075) 17075
female (11215) 11215
methotrexate (10963) 10963
male (9260) 9260
middle aged (7628) 7628
methotrexate - adverse effects (7222) 7222
adult (7122) 7122
methotrexate - administration & dosage (5473) 5473
methotrexate - therapeutic use (5422) 5422
aged (5361) 5361
treatment outcome (4160) 4160
arthritis, rheumatoid - drug therapy (3856) 3856
rheumatology (3738) 3738
oncology (3724) 3724
rheumatoid arthritis (3653) 3653
therapy (2912) 2912
adolescent (2907) 2907
antineoplastic combined chemotherapy protocols - therapeutic use (2814) 2814
chemotherapy (2656) 2656
drug therapy, combination (2522) 2522
child (2517) 2517
antineoplastic combined chemotherapy protocols - adverse effects (2496) 2496
antirheumatic agents - therapeutic use (2487) 2487
antirheumatic agents - adverse effects (2276) 2276
cancer (1912) 1912
care and treatment (1887) 1887
double-blind (1848) 1848
drug therapy (1738) 1738
retrospective studies (1738) 1738
pharmacology & pharmacy (1706) 1706
rheumatoid-arthritis (1650) 1650
arthritis (1600) 1600
child, preschool (1580) 1580
hematology (1546) 1546
risk factors (1524) 1524
medicine & public health (1496) 1496
efficacy (1467) 1467
drug administration schedule (1424) 1424
immunosuppressive agents - therapeutic use (1418) 1418
infliximab (1393) 1393
cyclophosphamide - administration & dosage (1325) 1325
time factors (1311) 1311
follow-up studies (1308) 1308
patients (1290) 1290
etanercept (1288) 1288
dose-response relationship, drug (1252) 1252
animals (1233) 1233
research (1233) 1233
disease (1192) 1192
children (1164) 1164
immunosuppressive agents - adverse effects (1151) 1151
toxicity (1133) 1133
dermatology (1128) 1128
pregnancy (1122) 1122
rheumatoid factor (1100) 1100
prospective studies (1073) 1073
psoriasis - drug therapy (1073) 1073
prognosis (1072) 1072
safety (1060) 1060
psoriasis (1052) 1052
analysis (1051) 1051
tumor necrosis factor-alpha - antagonists & inhibitors (1043) 1043
aged, 80 and over (1031) 1031
fluorouracil - administration & dosage (1026) 1026
health aspects (1022) 1022
breast neoplasms - drug therapy (1005) 1005
medicine, general & internal (1000) 1000
combined modality therapy (997) 997
antirheumatic agents - administration & dosage (986) 986
immunology (983) 983
cyclophosphamide - adverse effects (967) 967
young adult (966) 966
trial (962) 962
severity of illness index (956) 956
doxorubicin - administration & dosage (951) 951
pediatrics (950) 950
dosage and administration (946) 946
clinical trials (938) 938
remission induction (908) 908
antineoplastic agents - adverse effects (900) 900
antibodies, monoclonal - therapeutic use (894) 894
cisplatin - administration & dosage (854) 854
vincristine - administration & dosage (844) 844
risk (828) 828
antineoplastic combined chemotherapy protocols - administration & dosage (821) 821
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (815) 815
adalimumab (812) 812
cyclophosphamide (799) 799
low-dose methotrexate (799) 799
antimetabolites, antineoplastic - adverse effects (776) 776
infant (745) 745
double-blind method (722) 722
internal medicine (722) 722
diagnosis (717) 717
transplantation (714) 714
survival rate (713) 713
disease-free survival (711) 711
abridged index medicus (708) 708
management (698) 698
leukemia (696) 696
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19438) 19438
German (453) 453
French (319) 319
Japanese (311) 311
Spanish (161) 161
Russian (86) 86
Chinese (76) 76
Italian (70) 70
Polish (54) 54
Portuguese (47) 47
Danish (33) 33
Dutch (27) 27
Korean (19) 19
Norwegian (14) 14
Czech (12) 12
Hungarian (12) 12
Hebrew (10) 10
Swedish (9) 9
Finnish (7) 7
Serbian (5) 5
Bulgarian (4) 4
Croatian (4) 4
Persian (3) 3
Turkish (3) 3
Icelandic (2) 2
Romanian (2) 2
Slovak (2) 2
Arabic (1) 1
Latin (1) 1
Lithuanian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Internal Medicine, ISSN 0953-6205, 2014, Volume 25, Issue 10, pp. 900 - 908
Abstract Background Patients with chronic diseases often receive multiple medications and are associated with increased vulnerability to medication errors.... 
Internal Medicine | Safety management/organization and administration | High-alert medications | Patient safety | Chronic patient | Medication errors/prevention and control | EMERGENCY-DEPARTMENT VISITS | HOSPITAL ADMISSIONS | UNIT | ADVERSE DRUG EVENTS | SAFETY | RISK | PREVALENCE | CARE | OLDER PERSONS | MEDICINE, GENERAL & INTERNAL | PRESCRIPTIONS | Digoxin - adverse effects | Drug-Related Side Effects and Adverse Reactions - prevention & control | Antipsychotic Agents - adverse effects | Humans | Sodium Potassium Chloride Symporter Inhibitors - adverse effects | Mineralocorticoid Receptor Antagonists - adverse effects | Amiodarone - analogs & derivatives | Adrenal Cortex Hormones - adverse effects | Amiodarone - adverse effects | Cytostatic Agents - adverse effects | Methotrexate - adverse effects | Analgesics, Opioid - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anticonvulsants - adverse effects | Anti-Arrhythmia Agents - adverse effects | Adrenergic beta-Antagonists - adverse effects | Immunosuppressive Agents - adverse effects | Benzodiazepines - adverse effects | Spironolactone - analogs & derivatives | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Spironolactone - adverse effects | Chronic Disease - drug therapy | Platelet Aggregation Inhibitors - adverse effects | Drugs | Chronic diseases
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2013, Volume 31, Issue 5, pp. 592 - 598
Purpose To assess therapy-related acute myeloid leukemia/myelodysplastic syndrome (t-AML/MDS) risk in patients treated for Hodgkin lymphoma (HL) on successive... 
2ND CANCER-RISK | RANDOMIZED-TRIALS | ONCOLOGY | DNA TOPOISOMERASE-II | ALKYLATING-AGENTS | COMBINED-MODALITY TREATMENT | DISEASE | MYELOID-LEUKEMIA | MYELODYSPLASTIC SYNDROMES | CHEMOTHERAPY | ACUTE PROMYELOCYTIC LEUKEMIA | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Hodgkin Disease - pathology | Humans | Leukemia, Myeloid, Acute - epidemiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Mechlorethamine - adverse effects | Male | Risk | Leukemia, Myeloid, Acute - etiology | Incidence | Hodgkin Disease - radiotherapy | Melphalan - adverse effects | Chemotherapy, Adjuvant - adverse effects | Radiotherapy, Adjuvant - adverse effects | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Adult | Female | Retrospective Studies | Databases, Factual | Radiotherapy Dosage | Prednisone - adverse effects | Drug Administration Schedule | California - epidemiology | Clinical Trials as Topic | Bleomycin - adverse effects | Academic Medical Centers | Myelodysplastic Syndromes - epidemiology | Myelodysplastic Syndromes - etiology | Neoplasms, Second Primary - epidemiology | Neoplasms, Second Primary - etiology | Methotrexate - adverse effects | Procarbazine - adverse effects | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Hema14 | Hema13 | Hema12 | ORIGINAL REPORTS
Journal Article
The Lancet. Haematology, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Infections - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced
Journal Article
Gastroenterology, ISSN 0016-5085, 2016, Volume 150, Issue 2, pp. 380 - 388.e4
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 1460-2105, 2012, Volume 104, Issue 18, pp. 1386 - 1395
.... Univariate logistic regression was used to estimate the effect of intensity of chemotherapy (treatment arm... 
ATTENTION | LONG-TERM SURVIVORS | NEUROPSYCHOLOGICAL PERFORMANCE | ONCOLOGY | FRONTAL-CORTEX | DEVELOPMENTAL MODEL | SEX-DIFFERENCES | RADIATION | WHITE-MATTER VOLUME | WORKING-MEMORY | CHILDREN | Multivariate Analysis | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Age Factors | Humans | Precursor Cell Lymphoblastic Leukemia-Lymphoma - psychology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Dexamethasone - adverse effects | Infant | Male | Cytarabine - adverse effects | Patient Selection | Hydrocortisone - administration & dosage | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Time Factors | Attention - drug effects | Vincristine - administration & dosage | Female | Child | Injections, Spinal | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Prednisone - adverse effects | Drug Administration Schedule | Risk Factors | Mercaptopurine - administration & dosage | Mercaptopurine - adverse effects | Logistic Models | Treatment Outcome | Cognition - drug effects | Cranial Irradiation - adverse effects | Remission Induction | Cytarabine - administration & dosage | Intelligence Tests | Methotrexate - adverse effects | Hydrocortisone - adverse effects | Adolescent | Sex Factors | Vincristine - adverse effects | Methotrexate - administration & dosage | Intelligence - drug effects | Care and treatment | Patient outcomes | Acute lymphocytic leukemia | Research | Cognition disorders | Risk factors | Cancer in children
Journal Article
Drug safety, ISSN 0114-5916, 2000, Volume 23, Issue 5, pp. 429 - 448
...).Sulfasalazine consists of sulfapyridine linked to 5-aminosalicylic acid (5-ASA) via an azo bond. Common adverse effects related to sulfapyridine intolerance include headache, nausea, anorexia, and malaise... 
Mercaptopurine, general | Inflammatory bowel disease, treatment | Salicylates, general | Ciprofloxacin, general | Cyclosporin, general | Sulfasalazine, general | Azathioprine, general | Antibacterials, general | Metronidazole, general | Methotrexate, general | Tacrolimus, general | Immunomodulators, general | Mycophenolate mofetil, general | Aminosalicylic acid, general | Corticosteroids, general | RHEUMATOID-ARTHRITIS | LONG-TERM | RENAL-ALLOGRAFT RECIPIENTS | GLUCOCORTICOID-INDUCED OSTEOPOROSIS | ACTIVE CROHNS-DISEASE | RESISTANT ULCERATIVE-COLITIS | 5-AMINOSALICYLIC ACID | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | TOXICOLOGY | PLACEBO-CONTROLLED TRIAL | MYCOPHENOLATE-MOFETIL | Anti-Infective Agents - pharmacology | Humans | Immunosuppressive Agents - therapeutic use | Male | Sulfasalazine - pharmacology | Adrenal Cortex Hormones - therapeutic use | Prodrugs - metabolism | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Female | Immunosuppressive Agents - pharmacology | Inflammatory Bowel Diseases - drug therapy | Sulfasalazine - therapeutic use | Anti-Infective Agents - adverse effects | Mesalamine - adverse effects | Adrenal Cortex Hormones - pharmacology | Anti-Infective Agents - therapeutic use | Pregnancy | Adrenal Cortex Hormones - adverse effects | Gastrointestinal Agents - pharmacology | Mesalamine - pharmacology | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Gastrointestinal Agents - therapeutic use | Mesalamine - therapeutic use | Immunosuppressive Agents - adverse effects | Gastrointestinal Agents - adverse effects | Sulfasalazine - adverse effects
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2014, Volume 70, Issue 1, pp. 168 - 177
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2013, Volume 31, Issue 31, pp. 3971 - 3979
Journal Article
British journal of haematology, ISSN 0007-1048, 2014, Volume 167, Issue 3, pp. 394 - 401